-
Views
-
Cite
Cite
Samantha L. Wong, Daniela Martiniuc, Maija Kiuru, CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome, Clinical and Experimental Dermatology, Volume 47, Issue 12, 1 December 2022, Pages 2284–2285, https://doi.org/10.1111/ced.15354
- Share Icon Share
Abstract
CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF‐specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.
© 2022 British Association of Dermatologists
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
You do not currently have access to this article.